Mitochondria, the cellular powerhouses are integral to energy production and overall cellular function. Recent discoveries, like the study featured in STAT News, have unveiled an intriguing connection between these cellular dynamos, SARS-CoV-2, and the prolonged symptoms of long-haul COVID. At the same time, a Nature journal article shines a light on how hyperbaric oxygen therapy (HBOT) might hold the key to easing these persistent symptoms. Let’s take a closer look at the role of mitochondria, what the studies have revealed, and the potential of HBOT and microcurrent therapy in the quest to help long-haul COVID warriors.
Mitochondrial Marvels and Energy Production:
Picture mitochondria as the body’s energy factories, crafting a molecule called adenosine triphosphate (ATP) that powers all sorts of essential tasks. They work their magic through a process called oxidative phosphorylation, where nutrients and oxygen are turned into ATP, essential for muscle movement, metabolism, and more.
SARS-CoV-2’s Mitochondrial Hurdles:
The Science Translational Medicine study unveils how SARS-CoV-2 can disrupt the mitochondria. This disruption can lead to a shortage of ATP and hampered cellular energy. These glitches might be why long-haul COVID sufferers often feel drained, weak, and stuck with enduring symptoms.
Hyperbaric Oxygen Therapy’s Potential:
An article in Nature features hyperbaric oxygen therapy (HBOT) as a potential remedy for long-haul COVID. HBOT involves breathing pure oxygen in a pressurized chamber, enhancing oxygen delivery to tissues and potentially revitalizing mitochondrial function. This oxygen infusion might reboot mitochondria, pump up energy production, and help overcome those relentless symptoms. (Check out our other article for a deeper dive into the study.)
A Promising Path Forward with Frequency Specific Microcurrent:
Microcurrent stimulation, another innovative therapy, involves applying low-level electrical currents to the body. While not discussed in either of the articles, this technique aims to stimulate cellular activity, potentially aiding in restoring mitochondrial function and overall cellular health and has been shown to increase ATP production by up to 500%. Coupled with frequencies to target affected tissues, such as with Frequency Specific Microcurrent (FSM), This technique’s potential to stimulate cellular activity and restore mitochondrial function suggests a possible synergy with HBOT.
Conclusion:
The intricate interplay between mitochondria and SARS-CoV-2 sheds light on the underlying mechanisms of long-haul COVID. With hyperbaric oxygen therapy (HBOT) and Frequency Specific Microcurrent (FSM) stepping into the spotlight, a ray of hope shines through for those battling lingering symptoms. As research unfolds, the nexus between mitochondria, SARS-CoV-2, and innovative therapies we offer, such as Hyperbaric Oxygen Therapy (HBOT), and Frequency Specific Microcurrent (FSM), presents an opportunity to offer relief and recovery to those navigating the challenging journey of long-haul COVID
